Neuronetics Company

Neuronetics develops non-invasive therapies for psychiatric and neurological disorders.

Founded Date: 2003
Last Funding Type: Post-IPO Equity
Headquarters: Malvern, Pennsylvania, United States
Investors Number: 15
Technology: Neuromodulation
Employee Number: 101-250
Industry: Biotechnology, Health Care, Medical Device, Therapeutics
Estimated Revenue: $10M to $50M
Last Funding Date: 2021
Number Of Exists: N/A
Funding Status: IPO
Investor Type: N/A
Investment Stage: N/A
Total Funding: 248400000